EUVIMEDEUVIMED entdecken
Crossref

Estimating Residual Kidney Function in Patients on Hemodialysis Using Serum Uromodulin

David A Jaques iD, Valérie Jotterand Drepper, Nicola Marangon iD, Olivier Devuyst iD, Sophie De Seigneux, Patrick Saudan, Belen Ponte

Clinical Journal of the American Society of Nephrology · 15.10.2026

DOI: 10.2215/cjn.0000001247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 15.10.2026. Verfasst von David A Jaques und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Geneva University Hospitals, Geneva, Switzerland. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Hôpitaux Universitaires de Genève, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Serum uromodulin identified patients with residual kidney function on hemodialysis (residual urea clearance ≥2 ml/min per 35 L) with high accuracy. Reflecting tubular mass, not filtration, uromodulin was orthogonal to β 2 microglobulin; combining both had higher discrimination. A two-threshold strategy reliably ruled in patients with the more-than-2 ml/min per 35 L residual urea clearance threshold, avoiding the need for urine collection in most patients.

Background

Residual kidney function (RKF) monitoring is essential to safe incremental hemodialysis prescription. Yet the cumbersome nature of interdialytic urine collections represents a major barrier to routine implementation. We investigated serum uromodulin (UMOD), as a marker of functional renal mass, in identifying patients with clinically significant RKF on hemodialysis when used alone, or in combination with serum β 2 microglobulin, a traditional marker of glomerular filtration.

Methods

We conducted a prospective observational study of 151 patients on hemodialysis at 2 centers in Geneva, Switzerland. Serum UMOD and β 2 microglobulin were measured on predialysis samples, and residual urea clearance (KRU) was determined by interdialytic timed urine collection. The discriminative performance of each biomarker for identifying patients with KRU ≥2 ml/min per 35 L was assessed by receiver operating characteristic analysis, and the 2 markers were then combined using logistic regression. We applied a two-threshold gray-zone strategy, defining a priori rule-out and rule-in cutoffs to achieve ≥90% sensitivity and specificity, respectively.

Results

Of the 151 patients, 92 (61%) had KRU

Schlagwörter

Stichwörter der Autor:innen

dialysishemodialysishemodialysis adequacy

Autor:innen und Institutionen

  • Division of Nephrology, Geneva University Hospitals, Geneva, Switzerland.
  • Institute of Physiology, University of Zurich, Zurich, Switzerland.

ORCID-Profile: David A Jaques, Nicola Marangon, Olivier Devuyst

Förderung

  • Hôpitaux Universitaires de Genève
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Jaques, D. A., Jotterand Drepper, V., Marangon, N., Devuyst, O., De Seigneux, S., Saudan, P., & Ponte, B. (2026). Estimating Residual Kidney Function in Patients on Hemodialysis Using Serum Uromodulin. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001247

Vancouver

Jaques DA, Jotterand Drepper V, Marangon N, Devuyst O, De Seigneux S, Saudan P, et al. Estimating Residual Kidney Function in Patients on Hemodialysis Using Serum Uromodulin. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001247

BibTeX
@article{Jaques2026,
  author = {Jaques, David A and Jotterand Drepper, Valérie and Marangon, Nicola and Devuyst, Olivier and De Seigneux, Sophie and Saudan, Patrick and Ponte, Belen},
  title = {Estimating Residual Kidney Function in Patients on Hemodialysis Using Serum Uromodulin},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.2215/cjn.0000001247}
}
Kostenlos starten →